CHICAGO (AP) — Illinois will receive $1.3 million as part of a $35 million settlement with a pharmaceutical company over the marketing of an organ-transplant drug.
Illinois and 41 other states are involved in the settlement with Pfizer Inc., the parent company of Wyeth Pharmaceuticals Inc. The deal resolves allegations Wyeth misrepresented the uses of the drug Rapamune.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.